Tygacil (tigecycline) — CareFirst (Caremark)
Community-acquired bacterial pneumonia caused by susceptible isolates of Streptococcus pneumoniae (penicillin-susceptible isolates), including cases with concurrent bacteremia, Haemophilus influenzae, and Legionella pneumophila
Initial criteria
- Patient age ≥ 18 years
- Indicated infection proven or strongly suspected to be caused by susceptible bacteria
- Tygacil should not be used for diabetic foot infections
- Tygacil should not be used for hospital-acquired or ventilator-associated pneumonia
- Appropriate cultures obtained to isolate and identify organisms and determine susceptibility
- Use of Tygacil should be limited to treatment of infections proven or strongly suspected to be due to susceptible bacteria